Literature DB >> 1721374

Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Japanese FK 506 Study Group.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721374

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

2.  Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.

Authors:  S R Katari; M Magnone; R Shapiro; M Jordan; V Scantlebury; C Vivas; A Gritsch; J McCauley; T Starzl; A J Demetris; P S Randhawa
Journal:  Clin Transplant       Date:  1997-06       Impact factor: 2.863

3.  Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.

Authors:  P S Randhawa; A C Tsamandas; M Magnone; M Jordan; R Shapiro; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1996-03       Impact factor: 6.394

4.  Serum and urinary neopterin as markers in renal transplant patients.

Authors:  H Kameoka; S Takahara; Y Takano; A Moutabarrik; Y Kokado; M Ishibashi; T Sonoda; A Okuyama
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

5.  Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy.

Authors:  K Muraoka; K Fujimoto; X Sun; K Yoshioka; K Shimizu; M Yagi; H Bose; I Miyazaki; K Yamamoto
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Cytotoxic effects of FK506 on human renal proximal tubule cells in culture.

Authors:  M M Atcherson; A L Trifillis
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-09       Impact factor: 2.416
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.